Kaiser Permanente researchers have developed a new risk score that can be used by clinicians to determine patients with type 2 diabetes who are at risk for having dementia, according to a study in The Lancet Diabetes & Endocrinology. Researchers determined the score by examining information from two longitudinal cohorts of patients age 60 and older who had 10 or more years of follow-up recorded in the Kaiser Permanente Northern California Diabetes Registry. The risk score is based on factors such as age, education, diabetic foot disease, acute metabolic events, and cerebrovascular and cardiovascular disease.

Related Summaries